Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Delamillieure, P.
Constans, J.M.
Fernández, J.
Brazzo, P.
and
Dollfus, S.
2001.
Espectrometría de resonancia magnética de protones (ERMP) del tálamo en la esquizofrenia.
European psychiatry (Ed. Española),
Vol. 8,
Issue. 2,
p.
130.
Bunney, Blynn G.
Bunney, William E.
Stein, Richard
and
Potkin, Steven G.
2003.
Cortical pathology in schizophrenia: a review of data from the dorsolateral prefrontal cortex.
Current Opinion in Psychiatry,
Vol. 16,
Issue. ,
p.
S9.
Clinton, Sarah M
and
Meador-Woodruff, James H
2004.
Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities.
Schizophrenia Research,
Vol. 69,
Issue. 2-3,
p.
237.
Jakary, Angela
Vinogradov, Sophia
Feiwell, Robert
and
Deicken, Raymond F.
2005.
N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI.
Schizophrenia Research,
Vol. 76,
Issue. 2-3,
p.
173.
Kim, Hyeonjin
McGrath, Brent M.
and
Silverstone, Peter H.
2005.
A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI‐cycle) to psychiatric disorders—focus on magnetic resonance spectroscopy (MRS) studies.
Human Psychopharmacology: Clinical and Experimental,
Vol. 20,
Issue. 5,
p.
309.
Wobrock, T.
Scherk, H.
and
Falkai, P.
2005.
Magnetresonanzspektroskopie bei Schizophrenie.
Der Radiologe,
Vol. 45,
Issue. 2,
p.
124.
Tayoshi, Shin'Ya
Sumitani, Satsuki
Taniguchi, Kyoko
Shibuya-Tayoshi, Sumiko
Numata, Shusuke
Iga, Jun-ichi
Nakataki, Masahito
Ueno, Shu-ichi
Harada, Masafumi
and
Ohmori, Tetsuro
2009.
Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).
Schizophrenia Research,
Vol. 108,
Issue. 1-3,
p.
69.
Lutkenhoff, E S
van Erp, T G
Thomas, M A
Therman, S
Manninen, M
Huttunen, M O
Kaprio, J
Lönnqvist, J
O'Neill, J
and
Cannon, T D
2010.
Proton MRS in twin pairs discordant for schizophrenia.
Molecular Psychiatry,
Vol. 15,
Issue. 3,
p.
308.
Kim, Sang-Young
Choi, Chi-Bong
Lee, Hyun-Sung
Lee, Sung-Ho
Woo, Dong-Cheol
Kim, Hwi-Yool
Hong, Kwan-Soo
Lee, Chul-Hyun
and
Choe, Bo-Young
2010.
Reversal of myo-inositol metabolic level in the left dorsolateral prefrontal cortex of rats exposed to forced swimming test following desipramine treatment: an in vivo localized 1H-MRS study at 4.7 T.
Magnetic Resonance Imaging,
Vol. 28,
Issue. 10,
p.
1461.
Brugger, Stefan
Davis, John M.
Leucht, Stefan
and
Stone, James M.
2011.
Proton Magnetic Resonance Spectroscopy and Illness Stage in Schizophrenia—A Systematic Review and Meta-Analysis.
Biological Psychiatry,
Vol. 69,
Issue. 5,
p.
495.
Kraguljac, Nina Vanessa
Reid, Meredith
White, David
Jones, Rebecca
den Hollander, Jan
Lowman, Deborah
and
Lahti, Adrienne Carol
2012.
Neurometabolites in schizophrenia and bipolar disorder — A systematic review and meta-analysis.
Psychiatry Research: Neuroimaging,
Vol. 203,
Issue. 2-3,
p.
111.
Orliac, F.
and
Delamillieure, P.
2012.
Imagerie cérébrale en psychiatrie : indications et résultats.
EMC - Psychiatrie,
Vol. 9,
Issue. 3,
p.
1.
Bracken, Bethany K.
Rouse, Elizabeth D.
Renshaw, Perry F.
and
Olson, David P.
2013.
T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia.
Psychiatry Research: Neuroimaging,
Vol. 213,
Issue. 2,
p.
142.
Whitehurst, Thomas Samuel
Osugo, Martin
Townsend, Leigh
Shatalina, Ekaterina
Vava, Robert
Onwordi, Ellis Chika
and
Howes, Oliver
2020.
Proton Magnetic Resonance Spectroscopy of N-acetyl Aspartate in Chronic Schizophrenia, First Episode of Psychosis and High-Risk of Psychosis: A Systematic Review and Meta-Analysis.
Neuroscience & Biobehavioral Reviews,
Vol. 119,
Issue. ,
p.
255.
Yang, Yvonne S.
Smucny, Jason
Zhang, Huailin
and
Maddock, Richard J.
2023.
Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status.
NeuroImage: Clinical,
Vol. 39,
Issue. ,
p.
103461.
Comments
No Comments have been published for this article.